The North America dental bone graft substitute and barrier membrane market is expected to grow from US$ 293.65 million in 2022 to US$ 552.38 million by 2030. It is estimated to grow at a CAGR of 8.2% from 2022 to 2030.
The companies further aim to innovate regenerative technologies in dentistry. In December 2022, Neoss Group, which designs, manufactures, and sells dental implant treatment products, opened a new sales office in the Nordic region. The facility commenced operations in the Nordic region on December 01, 2022, to support dental professionals and their patients. In January 2021, Dentsply Sirona acquired Datum Dental, a leading provider of innovative OSSIX regenerative solutions. The acquisition enabled Dentsply Sirona to acquire the strong OSSIX biomaterial portfolio of Datum Dental, Ltd. It also offered it access to the patented GLYMATRIX technology of Datum Dental Ltd. GLYMATRIX mimics the natural collagen cycle in the body, i.e., a biochemical process called glycation. GLYMATRIX forms the basis of OSSIX products for guided bone regeneration, as well as guided tissue regeneration.
North America Dental Bone Graft Substitute and Barrier Membrane Market Overview
The North America North America dental bone graft substitute and barrier membrane market is segmented into the US, Canada, and Mexico. The US is expected to account for the largest share of the North America Dental Bone Graft Substitute and Barrier Membrane Market. The growth of the market in the US is attributed to the rise in the prevalence of dental diseases across the country, regular dental check-ups, and technological improvements.
Based on product, the North America dental bone graft substitute and barrier membrane market is bifurcated into dental bone graft substitutes and dental barrier membranes. The dental bone graft substitutes segment held a larger share of the North America dental bone graft substitute and barrier membrane market in 2022.
Based on procedures, the North America dental bone graft substitute and barrier membrane market is segmented into guided bone regeneration (GBR) procedures, guided tissue regeneration (GTR) procedures, sinus-lift and ridge-split procedures, alveolar ridge preservation (ARP), block-graft procedures, periodontal regeneration procedures, socket preservation, and others. The sinus-lift and ridge-split segment held the largest share of the North America dental bone graft substitute and barrier membrane market in 2022.
Based on end user, the North America dental bone graft substitute and barrier membrane market is segmented into hospitals, dental clinics, and others. The dental clinics segment held the largest share of the North America dental bone graft substitute and barrier membrane market in 2022.
Based on country, the North America dental bone graft substitute and barrier membrane market is segmented into the US, Canada, and Mexico. The US dominated the North America dental bone graft substitute and barrier membrane market in 2022.
Geistlich Pharma AG, Medtronic Plc, Dentsply Sirona Inc, ZimVie Inc, Regenity Biosciences Inc, Neoss UK & Ireland Ltd, Institut Straumann AG, and Resorba Medical GmbH are the leading companies operating in the North America dental bone graft substitute and barrier membrane market.
Reasons to Buy
Strategic Developments by Market Players Fuel North America Dental Bone Graft Substitute and Barrier Membrane Market
Development strategies such as product launches, mergers and acquisitions, and expansions boost the growth of the North America Dental Bone Graft Substitute and Barrier Membrane Market . In April 2023, ZimVie announced the launch of RegenerOss CC Allograft Particulate and RegenerOss Bone Graft Plug, which helped it extend its portfolio of biomaterials that are intended for filling extraction sockets and periodontal defects. The products are commercially available in North America. In May 2023, Straumann acquired GalvoSurge Dental AG, a Swiss medical device manufacturer. The acquired company specializes in implant care and maintenance solutions to support the treatment of peri-implantitis. In October 2022, Geistlich, specialized in the regeneration of bone, cartilage, and tissue, acquired Lynch Biologics, US. The acquisition helped Geistlich Pharma to strengthen its portfolio by adding Lynch Biologics, LLC's leading GEM 21S product to it. GEM 21S is based on a growth factor that accelerates bone formation and wound healing.The companies further aim to innovate regenerative technologies in dentistry. In December 2022, Neoss Group, which designs, manufactures, and sells dental implant treatment products, opened a new sales office in the Nordic region. The facility commenced operations in the Nordic region on December 01, 2022, to support dental professionals and their patients. In January 2021, Dentsply Sirona acquired Datum Dental, a leading provider of innovative OSSIX regenerative solutions. The acquisition enabled Dentsply Sirona to acquire the strong OSSIX biomaterial portfolio of Datum Dental, Ltd. It also offered it access to the patented GLYMATRIX technology of Datum Dental Ltd. GLYMATRIX mimics the natural collagen cycle in the body, i.e., a biochemical process called glycation. GLYMATRIX forms the basis of OSSIX products for guided bone regeneration, as well as guided tissue regeneration.
North America Dental Bone Graft Substitute and Barrier Membrane Market Overview
The North America North America dental bone graft substitute and barrier membrane market is segmented into the US, Canada, and Mexico. The US is expected to account for the largest share of the North America Dental Bone Graft Substitute and Barrier Membrane Market. The growth of the market in the US is attributed to the rise in the prevalence of dental diseases across the country, regular dental check-ups, and technological improvements.
North America Dental Bone Graft Substitute and Barrier Membrane Market Revenue and Forecast to 2030 (US$ Million)
North America Dental Bone Graft Substitute and Barrier Membrane Market Segmentation
The North America dental bone graft substitute and barrier membrane market is segmented into product, procedures, end user and country.Based on product, the North America dental bone graft substitute and barrier membrane market is bifurcated into dental bone graft substitutes and dental barrier membranes. The dental bone graft substitutes segment held a larger share of the North America dental bone graft substitute and barrier membrane market in 2022.
Based on procedures, the North America dental bone graft substitute and barrier membrane market is segmented into guided bone regeneration (GBR) procedures, guided tissue regeneration (GTR) procedures, sinus-lift and ridge-split procedures, alveolar ridge preservation (ARP), block-graft procedures, periodontal regeneration procedures, socket preservation, and others. The sinus-lift and ridge-split segment held the largest share of the North America dental bone graft substitute and barrier membrane market in 2022.
Based on end user, the North America dental bone graft substitute and barrier membrane market is segmented into hospitals, dental clinics, and others. The dental clinics segment held the largest share of the North America dental bone graft substitute and barrier membrane market in 2022.
Based on country, the North America dental bone graft substitute and barrier membrane market is segmented into the US, Canada, and Mexico. The US dominated the North America dental bone graft substitute and barrier membrane market in 2022.
Geistlich Pharma AG, Medtronic Plc, Dentsply Sirona Inc, ZimVie Inc, Regenity Biosciences Inc, Neoss UK & Ireland Ltd, Institut Straumann AG, and Resorba Medical GmbH are the leading companies operating in the North America dental bone graft substitute and barrier membrane market.
Reasons to Buy
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America Dental Bone Graft Substitute and Barrier Membrane Market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in North America Dental Bone Graft Substitute and Barrier Membrane Market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Table of Contents
1. Introduction
2. Executive Summary
3. Research Methodology
4. North America Dental Bone Graft Substitute and Barrier Membrane Market Landscape
5. North America Dental Bone Graft Substitute and Barrier Membrane Market - Key Industry Dynamics
6. Dental Bone Graft Substitute and Barrier Membrane Market - North America Market Analysis
7. North America Dental Bone Graft Substitute and Barrier Membrane Market - Revenue and Forecast to 2030 - by Product
8. North America Dental Bone Graft Substitute and Barrier Membrane Market - Revenue and Forecast to 2030 - by Procedures
9. North America Dental Bone Graft Substitute and Barrier Membrane Market - Revenue and Forecast to 2030 - by End User
10. North America Dental Bone Graft Substitute and Barrier Membrane Market - Country Analysis
11. North America Dental Bone Graft Substitute and Barrier Membrane Market Industry Landscape
12. North America Dental Bone Graft Substitute and Barrier Membrane Market, Key Company Profiles
13. Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Geistlich Pharma AG
- Medtronic Plc
- Dentsply Sirona Inc
- ZimVie Inc
- Regenity Biosciences Inc
- Neoss UK & Ireland Ltd
- Institut Straumann AG
- Resorba Medical GmbH
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 96 |
| Published | November 2023 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value in 2022 | 293.65 Million |
| Forecasted Market Value by 2030 | 552.38 Million |
| Compound Annual Growth Rate | 8.2% |
| Regions Covered | North America |
